The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Structure of Haplotype Blocks in the Human Genome
Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., et al. (2002) · Science · doi:10.1126/science.1069424 · Cited by 5,863
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Linkage Disequilibrium in Humans: Models and Data
Pritchard, J. K., & Przeworski, M. (2001) · The American Journal of Human Genetics · doi:10.1086/321275 · Cited by 1,274
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
Pedigree disequilibrium tests for multilocus haplotypes.
Dudbridge, F. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10252 · Cited by 1,135
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Rost, S., Fregin, A., Ivaskevicius, V., Conzelmann, E., Hörtnagel, K., Pelz, H.-J., Lappegard, K., Seifried, E., Scharrer, I., Tuddenham, E. G. D., et al. (2004) · Nature · doi:10.1038/nature02214 · Cited by 1,134
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001) · Chest · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,134
Higashi, M. K. (2002) · JAMA · doi:10.1001/jama.287.13.1690 · Cited by 1,048
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
Landefeld, C. S., & Beyth, R. J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90285-w · Cited by 893
Human P450 metabolism of warfarin
Kaminsky, L. S., & Zhang, Z.-Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00140-4 · Cited by 798
Identification of the gene for vitamin K epoxide reductase
Li, T., Chang, C.-Y., Jin, D.-Y., Lin, P.-J., Khvorova, A., & Stafford, D. W. (2004) · Nature · doi:10.1038/nature02254 · Cited by 707
D'Andrea, G., D'Ambrosio, R. L., Di Perna, P., Chetta, M., Santacroce, R., Brancaccio, V., Grandone, E., & Margaglione, M. (2005) · Blood · doi:10.1182/blood-2004-06-2111 · Cited by 699
Rettie, A. E., Korzekwa, K. R., Kunze, K. L., Lawrence, R. F., Eddy, A. C., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., & Trager, W. F. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00025a009 · Cited by 601
Taube, J., Halsall, D., & Baglin, T. (2000) · Blood · doi:10.1182/blood.v96.5.1816 · Cited by 392
Adverse drug events and medication errors in Australia
Runciman, W. B. (2003) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzg085 · Cited by 351
Scordo, M. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129321 · Cited by 344
CYP2C9 allelic variants: ethnic distribution and functional significance
Xie, H.-G., Prasad, H. C., Kim, R. B., & Stein, C. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00076-5 · Cited by 338
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin
Eby, C., Milligan, P. E., Banet, G. A., Duncan, J., McLeod, H. L., & Gage, B. F. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-06-0379 · Cited by 322
Pharmacogenetics of Warfarin Elimination and Its Clinical Implications
Takahashi, H., & Echizen, H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140080-00003 · Cited by 312
Furuya, H., Fernandez-Salguero, P., Gregory, W., Taber, H., Steward, A., Gonzalez, F. J., & Idle, J. R. (1995) · Pharmacogenetics · doi:10.1097/00008571-199512000-00008 · Cited by 278
Interindividual variability in sensitivity to warfarin-Nature or nurture?
Loebstein, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117444 · Cited by 260
Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population
Yasar, Ü., Eliasson, E., Dahl, M.-L., Johansson, I., Ingelman-Sundberg, M., & Sjöqvist, F. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9992 · Cited by 249
Genetic Modulation of Oral Anticoagulation with Warfarin
Colaizzo, D., D’Andrea, G., Brancaccio, V., Ciampa, A., Grandone, E., Di Minno, G., & Margaglione, M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614114 · Cited by 233
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin
Kamali, F., Khan, T. I., King, B. P., Frearson, R., Kesteven, P., Wood, P., Daly, A. K., & Wynne, H. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.001 · Cited by 218
Cell Biology: A Laboratory Handbook
Heintzmann, R. (2006) · Cited by 202
Pharmacogenetics of oral anticoagulants
Daly, A. K., & King, B. P. (2003) · Pharmacogenetics · doi:10.1097/00008571-200305000-00002 · Cited by 195
Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors
Wadelius, M., Sörlin, K., Wallerman, O., Karlsson, J., Yue, Q.-Y., Magnusson, P. K. E., Wadelius, C., & Melhus, H. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500220 · Cited by 191
Self-citationShikata, E., Ieiri, I., Ishiguro, S., Aono, H., Inoue, K., Koide, T., Ohgi, S., & Otsubo, K. (2004) · Blood · doi:10.1182/blood-2003-09-3043 · Cited by 159
Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype
Hillman, M. A., Wilke, R. A., Caldwell, M. D., Berg, R. L., Glurich, I., & Burmester, J. K. (2004) · Pharmacogenetics · doi:10.1097/01.fpc.0000114760.08559.dc · Cited by 144
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M., Raskob, G. E., Landefeld, S., & Kearon, C. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.511s · Cited by 124
Harrington, D. J., Underwood, S., Morse, C., Shearer, M. J., Tuddenham, E. G. D., & Mumford, A. D. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0540 · Cited by 121
Mechanism of action of warfarin. Warfarin and metabolism of vitamin K1
Bell, R. G., Sadowski, J. A., & Matschiner, J. T. (1972) · Biochemistry · doi:10.1021/bi00760a034 · Cited by 86
Fregin, A., Rost, S., Wolz, W., Krebsová, A., Müller, C. R., & Oldenburg, J. (2002) · Blood · doi:10.1182/blood-2002-03-0698 · Cited by 72
Sadler, J. E. (2004) · Nature · doi:10.1038/427493a · Cited by 71
Pharmacogenetics and Anticoagulant Therapy
Gage, B. F., & Eby, C. S. (2003) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000014598.24114.62 · Cited by 30
[27] Purification of vitamin K-dependent carboxylase from cultured cells
Berkner, K. L., & McNally, B. A. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)82117-9 · Cited by 17
Lingenfelter, S. E., & Berkner, K. L. (1996) · Biochemistry · doi:10.1021/bi9523318 · Cited by 17
Cited by
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809329 · Cited by 1,577
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
Gage, B., Eby, C., Johnson, J., Deych, E., Rieder, M., Ridker, P., Milligan, P., Grice, G., Lenzini, P., Rettie, A., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.10 · Cited by 847
Anderson, J. L., Horne, B. D., Stevens, S. M., Grove, A. S., Barton, S., Nicholas, Z. P., Kahn, S. F. S., May, H. T., Samuelson, K. M., Muhlestein, J. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.737312 · Cited by 727
Johnson, J., Caudle, K., Gong, L., Whirl‐Carrillo, M., Stein, C., Scott, S., Lee, M., Gage, B., Kimmel, S., Perera, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.668 · Cited by 716
Self-citationJohnson, J. A., Gong, L., Whirl-Carrillo, M., Gage, B. F., Scott, S. A., Stein, C. M., Anderson, J. L., Kimmel, S. E., Lee, M. T. M., Pirmohamed, M., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.185 · Cited by 647
Self-citation
Metadata
- Authors
- Wadelius, M., Chen, L. Y., Downes, K., Ghori, J., Hunt, S., Eriksson, N., Wallerman, O., Melhus, H., Wadelius, C., Bentley, D., & Deloukas, P.
- Venue
- The Pharmacogenomics Journal
- Published
- 2005-05-10
- Volume
- 5
- Issue
- 4
- Pages
- 262-270
- ISSN
- 1470-269X (ISSN-L)
- 1473-1150
- OpenAlex
- W2038118250
- Cited by
- 468
- References
- 37
- FWCI
- 29.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.